参考文献/References:
[1] BEAM E,LESNICK T,KREMERS W,et al.Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis[J].Clin Transplant,2016,30(3):270-278.
[2] 中华医学会器官移植学分会.中国肺移植术后并发症诊疗和随访技术规范(2019版)[J].中华移植杂志:电子版,2019,13(2):99-108.
[3] 赵晓溪,陈静瑜,王如兴.肺移植术后房颤研究进展[J].实用心电学杂志,2021,30(5):360-363.
[4] JESEL L,BARRAUD J,LIM HS,et al.Early and late atrial arrhythmias after lung transplantation-incidence, predictive factors and impact on mortality[J].Circ J,2017,81(5):660-667.
[5] 赵从敏,杜爱燕,周薇,等.连续性肾脏替代治疗救治心肺联合移植术后严重肺积水并发急性肾衰竭患者1例的护理[J].解放军护理杂志,2018,35(9):61-63.
[6] 蔡英华,姚勇.肺移植临床护理实践[M].南京:东南大学出版社,2021:106.
[7] POTENA L,SOLIDORO P,PATRUCCO F,et al.Treatment and prevention of cytomegalovirus infection in heart and lung transplantation:an update[J].Expert Opin Pharmacother,2016,17(12):1611-1622.
[8] SARMIENTO E,CIFRIAN J,CALAHORRA L,et al.Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections:a multicenter prospective study[J].J Heart Lung Transplant,2018,37(8):1001-1012.
[9] 孙梦,温宗梅.肺移植术后巨细胞病毒感染的研究进展[J].实用临床医学,2018,19(11):100-102,106.
[10]BENZIMRA M,CALLIGARO G L,GLANVILLE A R.Acute rejection[J].J Thorac Dis,2017,9(12):5440-5457.
[11]中华医学会器官移植学分会.中国肺移植免疫抑制治疗及排斥反应诊疗规范(2019版)[J].中华移植杂志,2019,13(2):94-98.
[12]中华医学会器官移植学分会.肺移植护理技术操作规范[J].实用器官移植电子杂志,2019,7(5):340-342.
[13]林燕,俞超,王奉涛,等.2例异基因造血干细胞移植术后移植物抗宿主病患者行肺移植术的护理[J].中华护理杂志,2022,57(4):481-486.